Cvs Health (CVS) Operating Leases (2019 - 2026)

Cvs Health (CVS) has reported Operating Leases for 8 consecutive years, with $13.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 9.39% year-over-year to $13.0 billion; the trailing twelve-month figure through Jun 2026 stood at $13.0 billion (down 9.39% YoY), and the FY2025 full-year result was $13.6 billion, down 18.06% from the prior year.
• Operating Leases slipped to $13.0 billion in Q2 2026 per CVS's latest filing, from $13.3 billion in the prior quarter.
• Across five years, Operating Leases topped out at $18.5 billion in Q4 2022 and bottomed at $13.0 billion in Q2 2026.
• Historically, Operating Leases has averaged $15.8 billion across 5 years, with a median of $16.1 billion in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Leases retreated 4.12% in 2023, then slipped 18.06% in 2025.
• Over 5 years, Operating Leases stood at $18.5 billion in 2022, then dropped by 4.12% to $17.8 billion in 2023, then decreased by 6.33% to $16.7 billion in 2024, then declined by 18.06% to $13.6 billion in 2025, then dropped by 4.84% to $13.0 billion in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $13.0 billion, $13.3 billion, and $13.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.